HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Metabotropic glutamate antagonists alone and in combination with morphine: comparison across two models of acute pain and a model of persistent, inflammatory pain.

Abstract
The present study examined the effects of the mGluR1 antagonist JNJ16259685 (JNJ) and the mGluR5 antagonist 2-methyl-6-phenylethynylpyridine (MPEP) alone and in combination with morphine in two acute pain models (hotplate, warm water tail-withdrawal), and a persistent, inflammatory pain model (capsaicin). In the hotplate and warm water tail-withdrawal procedures, JNJ and MPEP were ineffective when administered alone. In both procedures, JNJ potentiated morphine antinociception. In the hotplate procedure, MPEP potentiated morphine antinociception at the highest dose examined, whereas in the warm water tail-withdrawal procedure MPEP attenuated morphine antinociception at a moderate dose and potentiated morphine antinociception at a high dose. For both JNJ and MPEP, the magnitude of this morphine potentiation was considerably greater in the hotplate procedure. In the capsaicin procedure, the highest dose of MPEP produced intermediate levels of antihyperalgesia and also attenuated the effects of a dose of morphine that produced intermediate levels of antihyperalgesia. In contrast, JNJ had no effect when administered alone in the capsaicin procedure and did not alter morphine-induced antihyperalgesia. The present findings suggest that the effects produced by mGluR1 and mGluR5 antagonists alone and in combination with morphine can be differentiated in models of both acute and persistent pain.
AuthorsMitchell J Picker, Dana Daugherty, Fredrick E Henry, Laurence L Miller, Linda A Dykstra
JournalBehavioural pharmacology (Behav Pharmacol) Vol. 22 Issue 8 Pg. 785-93 (Dec 2011) ISSN: 1473-5849 [Electronic] England
PMID21971021 (Publication Type: Comparative Study, Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • (3,4-dihydro-2H-pyrano(2,3)b-quinolin-7-yl)-(cis-4-methoxycyclohexyl) methanone
  • Excitatory Amino Acid Antagonists
  • Narcotics
  • Pyridines
  • Quinolines
  • Receptors, Metabotropic Glutamate
  • Morphine
  • 6-methyl-2-(phenylethynyl)pyridine
  • Capsaicin
Topics
  • Animals
  • Behavior, Animal (drug effects)
  • Capsaicin
  • Disease Models, Animal
  • Drug Therapy, Combination
  • Excitatory Amino Acid Antagonists (pharmacology, therapeutic use)
  • Inflammation (drug therapy)
  • Male
  • Morphine (pharmacology, therapeutic use)
  • Narcotics (therapeutic use)
  • Pain (chemically induced, drug therapy)
  • Pain Measurement (drug effects)
  • Pyridines (pharmacology, therapeutic use)
  • Quinolines (pharmacology, therapeutic use)
  • Rats
  • Rats, Inbred F344
  • Receptors, Metabotropic Glutamate (antagonists & inhibitors)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: